Tag: Tandem Diabetes Care
Product launches: ResMed, Tandem Diabetes Care
February 13, 2024HME News Staff
ResMed has launched its AirCurve 11 series of bilevel devices. The AirCurve 11 uses two levels of support – inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP) –and is also built on the company’s AirSense 11 platform. Other features include integrated heated humidifier, engagement tools like AirView, myAir and Personal Therapy Assistant. “Patient care is our top priority, and that includes their comfort and compliance with PAP therapy,”...
Abbott, Tandem integrate
January 9, 2024HME News Staff
ABBOTT PARK, Ill., and SAN DIEGO – Abbott and Tandem Diabetes Care have announced that the t:slim X2 insulin pump with Control-IQ technology is the first automated insulin delivery system to integrate with the newly available FreeStyle Libre 2 Plus sensor. For the first time, FreeStyle Libre technology users in the United States are now able to experience the therapeutic benefits of a hybrid closed-loop system that helps predict and prevent high and low blood sugar. “Tandem’s leadership...
Tandem launches diabetes management platform
December 20, 2023HME News Staff
SAN DIEGO – Tandem Diabetes Care has launched Tandem Source, a diabetes management platform for insulin pump users and health care providers. Tandem Source brings together the features of Tandem’s legacy t:connect, t:connect HCP, and t:connect Portal offerings with new comprehensive data reporting in one central, scalable platform. “The launch of Tandem Source offers new, easy-to-use reports and the consolidation of several platforms and features into a single, convenient location...
In brief: Inogen buy, UPitt grant, telehealth decrease
July 14, 2023HME News Staff
GOLETA, Calif. - Inogen has entered into a definitive agreement to acquire Physio-Assist SAS, a privately held company based in France that makes a technology-enabled airway clearance device called Simeox, for $32 million.
Simeox has been cleared under CE mark in the EU and is currently being sold in Europe, Asia and the Middle East.
“This acquisition aligns with our strategy to diversify our portfolio to globally improve patient lives through respiratory care,” said...
Tandem Mobi gets FDA approval
July 13, 2023HME News Staff
SAN DIEGO – Tandem Diabetes Care has received U.S. Food and Drug Administration clearance for the Tandem Mobi insulin pump for people with diabetes age 6 and up. The Tandem Mobi is fully controllable from a mobile app. “Testing the limits of pump miniaturization, Tandem Mobi joins the t:slim X2 pump in our family of insulin delivery solutions bringing new options in wearability, the flexibility to disconnect, and full phone control,” said John Sheridan, president and CEO. “Through...
Tandem study shows great improvement for high A1c
April 18, 2023HME News Staff
SAN DIEGO – Tandem Diabetes Care, has published the result of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. The results, published in Diabetes Technology & Therapeutics demonstrate the positive clinical impact of the system’s automatic correction bolusing on glucose control across a wide range of ages and demographics of people with Type 1 diabetes. People with the highest baseline blood sugar levels experienced the greatest...
In brief: Homecare Champ, new home infusion code, supplies survey, seat elevation comments
March 24, 2023HME News Staff
DALLAS – Kam Yuricich has been named the 2023 Van Miller Homecare Champion for her achievements as the executive director for OAMES and the Great Lakes Home Medical Equipment Association.
Yuricich will be honored at the Stand Up For Homecare reception at Medtrade in Dallas on Wednesday, March 29.
“Kam is a star and a stalwart for HME,” says Tom Ryan, AAHomecare president and CEO. “She’s brought home bottom-line wins for her members and she’s also...
Tandem backs use of insulin pump
November 15, 2022HME News Staff
SAN DIEGO – Tandem Diabetes Care has announced the results from a prospective, multi-center, single-arm study of adults living with Type 2 diabetes who achieved improvement in all clinical endpoints with the use of the t:slim X2 insulin pump with Control-IQ technology. Data from the study, which was presented at the 22nd Annual Diabetes Technology Meeting, demonstrated the system to be safe during six weeks of use, with a substantial improvement in time in range and mean glucose related to...
Tandem names ResMed exec to board
December 16, 2020HME News Staff
SAN DIEGO – Tandem Diabetes Care has named Raj Sodhi, president of the software as a service (SaaS) business at ResMed, as an independent member of its board of directors effective Jan. 1. He brings to Tandem more than 25 years of digital strategy experience, SaaS commercialization and operations across multiple industries, including health care, financial services and telecom. “We are pleased to welcome Raj to our board of directors at this important next stage of Tandem’s...
Tandem reports sales increase
May 1, 2019HME News Staff
SAN DIEGO - Tandem Diabetes Care reported sales increased to $66 million for the first quarter of 2019, a 142% over the same time period one year ago. Pump shipments increased from 4,444 to 14,732 during the same period, an increase of 232%. Gross profit for the quarter was $33.4 million compared to $11.4 million for the same quarter in 2018. “Our explosive growth in the first quarter was driven by strong domestic demand for the t:slim X2 insulin pump,” said John Sheridan, president and...